Sho Sugawara
Papers
3
Total Citations
21
H-Index
3
About
Dr. Sho Sugawara is a rising leader in urologic oncology, whose work is redefining surgical precision and personalized treatment for prostate and bladder cancers. His primary research focuses on advancing robot-assisted radical prostatectomy, where he has pioneered novel nerve-sparing techniques that preserve the endopelvic fascia. This work, detailed in his highly cited 2024 paper, demonstrates a critical balance between achieving excellent long-term oncological control and superior functional outcomes, such as continence, for patients. With over 11 citations, this study provides essential long-term data that validates these innovative surgical approaches. Beyond the operating room, Dr. Sugawara is at the forefront of integrating genomics into clinical practice. He reported a landmark case of pathological complete response in the aggressive plasmacytoid variant of bladder cancer following pembrolizumab therapy guided by genomic analysis, showcasing the power of precision oncology. He has also developed and validated a novel nomogram for the robotic era, which accurately identifies candidates for extended pelvic lymph node dissection in prostate cancer, helping to avoid unnecessary procedures. Through these contributions—spanning surgical innovation, predictive modeling, and targeted therapy—Dr. Sugawara is shaping a future where urologic cancer care is both more effective and more tailored to the individual patient.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3